Catalyst Wire Dossier Catalyst Wire Dossier

CD1579 gel (concentration 2)

CD1579 · Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD1579 gel (concentration 2), covering 2016-11-03 to 2016-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. [Phase 2]

See pricing